Craft

Berry Genomics

Stock Price

¥7.2

2024-04-19

Market Capitalization

¥2.5 B

2024-04-19

Revenue

¥1.3 B

FY, 2022

Berry Genomics Summary

Company Summary

Overview
Berry Genomics (贝瑞基因) is a biotechnology company that develops sequencing-based integrated solutions for life sciences and clinical applications. The company focuses on genetic testing and oncology testing.
Type
Public
Status
Active
Founded
2010
HQ
CN | view all locations
Website
https://www.berrygenomics.com/
Cybersecurity rating
ESG rating
30-39 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Beijing Shi HQ

    China

Berry Genomics Financials

Summary Financials

Revenue (Q3, 2023)
¥313.6M
Gross profit (Q3, 2023)
¥145.6M
Net income (Q3, 2023)
(¥39.3M)
Cash (Q3, 2023)
¥286.7M
EBIT (Q3, 2023)
(¥20.4M)
Enterprise value
$2.6B

Footer menu